Healthcare - Medical - Devices - NASDAQ - US
$ 4.22
2.93 %
$ 54.3 M
Market Cap
-6.49
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
315.36%
EBIT
Estimate
91.92%
Net Income
Estimate
35.11%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Nexalin Technology, Inc.
NXL has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart NXL
EBIT FORECAST
EBIT Forecast Chart NXL
NET INCOME FORECAST
Net Income Chart NXL